CDC Assisted Reproductive Technology (ART) Data Collection

- All questions must be submitted in writing and emailed to Ronnie Williams at [email protected] no later than 3:00 pm, on or before August 16, 2022. Questions shall identify the pertinent RFP Section, page number and paragraph number. To ensure a prompt response, identify: “75D301-22-R-72440 Questions” in the email “subject” line. - Proposal Due Date: Proposal is due no later than 3:00 pm, EST, September 2, 2022. Official proposal must be submitted electronically to [email protected] by the scheduled date and time. Reference: #75D301-22-R-72440 ----------------------------------------------------------------------------------------------------- The purpose of this project is to assist the Centers for Disease Control and Prevention (CDC) with collecting data from all practicing ART programs in the United States and its territories for ART procedures initiated in years 2023 – 2025 via the National ART Surveillance System (NASS), and to assist with preparing appendixes for the annual ART Fertility Clinic and National Summary report for reporting years 2023-2025 as required in the FCSRCA, Section 2[a] of P.L. 102-493 [42 U.S.C. 263 (a)-1]. NASS is currently operated by Westat, Inc. under contract number 75D301-20-F-07168. The final year of data that will be reported under this new contract will be 2025 data, reported in 2027. The successful contractor, as an independent organization and not as an agent of the Government, shall furnish all personnel, facilities, equipment, supplies, materials, procedures, and technical support necessary to assist CDC in collecting ART program data and producing appendixes of the annual ART Fertility Clinic and National Summary Report, as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA), P.L. 102-493.